The Treatment of Patients With Type 1 Diabetes Mellitus With Autologous Tolerogenic Dendritic Cells

NCT05207995 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
32
Enrollment
OTHER_GOV
Sponsor class

Conditions

Interventions

Sponsor

Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus

Collaborators